U.S. Releases PFAS Regulation and Accountability Act of 2026, Phasing Out Non-Essential Uses Within 10 Years

On March 19, 2026, the Congressional Record of the U.S. Senate published Bill S.4153 - the Forever Chemical Regulation and Accountability Act of 2026. The bill proposes a comprehensive phase-out of per- and polyfluoroalkyl substances (PFAS) and the establishment of a robust regulatory framework.

Main Contents of the Bill

I. Annual Monitoring and Reporting Requirements (Section 102(a))

Rulemaking Timeline: Within 3 years of the Act's effective date, the Administrator of the Environmental Protection Agency (EPA) must issue a final rule requiring PFAS manufacturers and users to submit reports.
Reporting Content Requirements (Initial Report and Annual Updates): Manufacturers and users must submit an initial report within 18 months after the rule is issued, followed by annual submissions. The content includes:

Reporting Item	Specific Content
Essential Use Description	Function of PFAS in the product/process, usage amount and concentration, trade name, chemical identity, and molecular structure
Safer Alternatives	Alternative PFAS solutions currently in use
Environmental Releases	Any detectable levels of PFAS releases
Federally Required Uses	PFAS uses mandated by federal law, standards, or government specifications
Non-Essential Use Description	Detailed description of all non-essential uses
Total Production/Processing Volume	Total volume manufactured or processed for each PFAS, and estimated volumes by use category
Byproducts	Byproducts generated during manufacturing, processing, use, or disposal
Environmental & Health Impacts	All available information on the environmental and health impacts of the PFAS
Exposed Population	Number of people exposed in the workplace and duration of exposure
Disposal Methods	Method of disposal or destruction for each PFAS (initial report and upon change)
Additional Information	Other information requested by the Administrator

II. Production and Consumption Phase-Out Timeline (Section 102(b))

Overall Phase-Out Deadline: Manufacturers and users must completely phase out non-essential uses within 10 years of the Act's effective date.

III. Accelerated Phase-Out Schedule for Specific Products (Section 102(b)(4))

Time After Enactment	Products Prohibited from Sale	Exceptions
1 Year	Carpets/rugs, fabric treatments, food packaging and containers, children's products, oil and gas products containing PFAS	Second-hand products may continue to be sold
2 Years	Cosmetics, indoor textiles, indoor upholstered furniture, accessories/handbags, indoor and outdoor apparel containing PFAS
4 Years	Outdoor textiles, outdoor upholstered furniture containing PFAS
5 Years	Outdoor apparel for severe wet conditions containing PFAS (intentionally added)

IV. Scope of Application

Applies to all U.S. states, territories, freely associated states, Indian tribes, and the District of Columbia.
Does not apply to entities that only receive PFAS in the course of their regular operations (e.g., solid waste management facilities, public water systems, etc.).

About CIRS

Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services from regulatory compliance, laboratory testing, R&D to data services across multiple industries. This includes chemicals, cosmetics, food and food beverages, medical devices, agrochemical products, disinfectants, and consumer goods. It helps clients gain a competitive advantage by reducing business risks associated with regulatory affairs.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

Document

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.